Team Leader
US Food and Drug Administration
Bilal is currently working as a clinical pharmacology team leader for the neurology team 1 (acting) at FDA. Bilal received his pharmacy degree from the University of Jordan in 2005. After graduation from pharmacy school, Bilal worked for two years in the pharmaceutical industry as an R&D scientist. Bilal received his PhD in Pharmaceutical Sciences and Pharmacokinetics from the University of Louisiana at Monroe in 2011. The focus of his PhD was on the application of PBPK modeling and simulations in predicting the nonlinear pharmacokinetics of small molecules. After graduation, he joined University of Cincinnati to complete a two-year postdoctoral training in clinical pharmacology and PK/PD analysis. During his postdoctoral training, Bilal was involved in designing phase I clinical trials and was working on the application of PBPK modeling in dose selection for oncology drug combination products. In 2013, Bilal joined the Office of Clinical Pharmacology as a reviewer in the neurology team in DNP (previously DCPI). During his work at FDA, Bilal developed special interest in rare disease drug development and the application of exposure response analysis to support the approval of modified release drug products.
Disclosure information not submitted.
Monday, January 10, 2022
3:15 PM – 4:15 PM ET
Wednesday, March 16, 2022
3:00 PM – 4:00 PM ET
.png)